The data revealed that the overexpression of STX2 clearly promoted the growth of SW480 and HCT116 in vitro, and the downregulation of STX2 clearly inhibited the proliferative ability of CRC cells (Figure 2D-K). Here, STX2 is linked to colorectal carcinoma.